Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $2.5700 (-1.15%) ($2.5700 - $2.5700) on Fri. Nov. 5, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.99% (three month average) | RSI | 32 | Latest Price | $2.5700(-1.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -0.4% a day on average for past five trading days. | Weekly Trend | ANPC declines -4.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) SHY(15%) UUP(15%) UNG(9%) VCSH(9%) VXX(9%) | Factors Impacting ANPC price | ANPC will decline at least -1.495% in a week (0% probabilities). CEMB(-20%) XLP(-18%) EMHY(-18%) BWX(-18%) VFMO(-17%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.495% (StdDev 2.99%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $2.8 | 5 Day Moving Average | $2.6(-1.15%) | 10 Day Moving Average | $2.67(-3.75%) | 20 Day Moving Average | $2.8(-8.21%) | To recent high | -26.1% | To recent low | 0% | Market Cap | $22m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |